Andrew H Limper

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Tyrosine Kinase

Lipopolysaccharide Induced

Saccharomyces Cerevisiae

Top Venues

Antimicrobial agents and chemotherapy

Leukemia & lymphoma

Cancer medicine

Cellular microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Characterization of the Pneumocystis jirovecii and Pneumocystis murina phosphoglucomutases (Pgm2s): a potential target for Pneumocystis therapy. Antimicrobial agents and chemotherapy 68 (3) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting host tyrosine kinase receptor EphA2 signaling via small-molecule ALW-II-41-27 inhibits macrophage pro-inflammatory signaling responses to Pneumocystis carinii β-glucans. Antimicrobial agents and chemotherapy 68 (2) (2024)
Mikhaila L Rice, Jason N Barreto, Carrie A Thompson, Kristin C Cole, Pritish K Tosh, Andrew H Limper
Incidence of Pneumocystis jirovecii pneumonia utilizing a polymerase chain reaction-based diagnosis in patients receiving bendamustine. Cancer medicine 10 (15) (2021)
Theodore J Kottom, Eva M Carmona, Andrew H Limper
Targeting CARD9 with Small-Molecule Therapeutics Inhibits Innate Immune Signaling and Inflammatory Response to Pneumocystis carinii β-Glucans. Antimicrobial agents and chemotherapy 64 (11) (2020)
Theodore J Kottom, Vijayalakshmi Nandakumar, Deanne M Hebrink, Eva M Carmona, Andrew H Limper
A critical role for CARD9 in pneumocystis pneumonia host defence. Cellular microbiology 22 (10) (2020)
Jason N Barreto, Carrie A Thompson, Patrick M Wieruszewski, Amanda G Pawlenty, Kristin C Cole, Ashley L Potter, Pritish K Tosh, Andrew H Limper
Incidence, clinical presentation, and outcomes of Pneumocystis pneumonia when utilizing Polymerase Chain Reaction-based diagnosis in patients with Hodgkin lymphoma. Leukemia & lymphoma 61 (11) (2020)